A Phase 1, Randomized, Open-Label, Single Dose, 4-Way Crossover Study In Healthy Volunteers To Assess The Relative Bioavailability Of The Oral Powder In Capsule (PIC) And An Immediate Release (IR) Film-Coated Tablet Of PH-797804 In The Fed And Fasted State.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2015
At a glance
- Drugs PH 797804 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 20 May 2009 Actual initiation date changed from 1 Mar 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
- 06 Mar 2009 Planned initiation date changed from 1 Feb 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 24 Jan 2009 New trial record.